Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04192656
PHASE4

The Effect of PAP on ISSHL Comorbided With OSA

Sponsor: Beijing Tsinghua Chang Gung Hospital

View on ClinicalTrials.gov

Summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Official title: The Effect of Positive Airway Pressure on Idiopathic Sudden Sensorineural Hearing Loss Comorbided With Obstructive Sleep Apnea: A Clinical Randomized Controlled Study

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2019-11-01

Completion Date

2029-12

Last Updated

2019-12-10

Healthy Volunteers

No

Interventions

DEVICE

non-invasive positive airway pressure

non-invasive positive airway pressure is the first-line treatment for obstructive sleep apnea

DRUG

Methylprednisolone Hemisuccinate

Methylprednisolone is the first-line treatment of idiopathic sudden sensorineural hearing loss

DRUG

Ginaton

ginnaton is ginkgo biloba extract

Locations (1)

Beijing Tsinhgua Changgung Hospital

Beijing, Beijing Municipality, China